Hemodynamic Effects at Rest and during Exercise in Long‐term Treatment with Prazosin in Chronic Congestive Heart Failure

Abstract
The long‐term effects of prazosin in chronic congestive heart failure were studied in 10 patients (New York Heart Association class III‐IV) in a double‐blind cross‐over study. Patients with systolic blood pressure > 120 mmHg and left ventricular filling pressure > 15 mmHg were included. Prazosin lowered the arteriovenous oxygen difference both at rest and during exercise (p < 0.05), increased cardiac index (p < 0.01) and reduced right atrial pressure and systemic vascular resistance (p < 0.05) during exercise. Left ventricular filling pressure was also reduced, but not significantly, during exercise. Our data show that prazosin has beneficial long‐term effects during exercise in patients with chronic congestive heart failure.